同仁堂国药（03613）于2026年4月2日发布2026年3月股份变动月报。公告显示，截至2026年3月31日，公司已发行普通股837,100,000股，较上月底无新增发行或回购注销，库存股份维持为0股，股本总数保持稳定。
报告期内，无股份期权或其他股权激励计划的新增授出、行使或失效记录，也未发生可转换债券、认股权证或其他形式的股份发行及购回。同时，公司表示将继续符合香港联交所上市规则及相关法律法规。
上述报告由公司秘书曾凤仪签署。根据公告内容，截至2026年3月31日，同仁堂国药的股本结构保持不变。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.